Glaxo challenges $2.7 billion transfer pricing claim April 17 2004 X LinkedIn Email Show more sharing options Copy Link URLCopied! Print X LinkedIn Email GlaxoSmithKline Holdings on April 2 2004 filed a petition in the US Tax Court contesting a multibillion-dollar transfer pricing claim Unlock this content. The content you are trying to view is exclusive to our subscribers. To unlock this content: Take a Free Trial or Login